Illumina Inc. announced that the Queensland Centre for Medical Genomics, home of Australia's International Cancer Genomics Consortium program, has established Illumina technology as its core sequencing platform in an expanded facility. The QCMG will replace their fleet of SOLiD/5500 systems with three Illumina HiSeq 2500 systems. This new partnership began in April. The decision of the QCMG to decommission their SOLiD/5500 systems and standardize on Illumina's 2500 platform for high-throughput next generation sequencing is a strong endorsement of the superior capabilities of the HiSeq platform and will assist the QCMG to progress towards its shared vision of enabling the development of personalized medicine.